Retrospective evaluation of obstetric processes in patients with Behçet’s disease
PDF
Cite
Share
Request
Original Article
P: 149-153
November 2023

Retrospective evaluation of obstetric processes in patients with Behçet’s disease

J Turk Soc Rheumatol 2023;15(3):149-153
1. Sağlık Bilimleri Üniversitesi, Başakşehir Çam ve Sakura Şehir Hastanesi, İç Hastalıkları Kliniği, Romatoloji Bölümü, İstanbul, Türkiye
2. Marmara Üniversitesi Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji ve Genetik Anabilim Dalı, İstanbul, Türkiye
3. İstanbul Medipol Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, İstanbul, Türkiye
4. Sağlık Bilimleri Üniversitesi, Başakşehir Çam ve Sakura Şehir Hastanesi, İç Hastalıkları Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 06.05.2023
Accepted Date: 14.08.2023
Publish Date: 27.11.2023
PDF
Cite
Share
Request

ABSTRACT

Objective:

Behçet’s disease (BD) is a multisystemic vasculitis affecting both gender and usually diagnosed in reproductive age. In this study, we aimed to investigate the relation between BD and pregnancy on the both maternal and fetal aspects.

Methods:

In this retrospective, single-center, descriptive study we analysed total 61 pregnancies of 18 BD patients. Clinical and demographic data were obtained from patients records regarding maternal age, disease histroy, obstetric history, pregnancy outcome and both maternal and fetal complicaitons. To prevent recall bias, only the recent pregnancy of each patient were evaluated for disease activity and use or revision of medicaitons during pregnancy.

Results:

The median age of the patients at diagnosis was 25 and first pregnancy age was 24.5 years. The median duration of BD during pregnancy was 3.5 years. Only one patient needed to in vitro fertilization to become pregnant. All patients were in remission before recent pregnancy. Fourteen (77.8%) patients had no symptoms during recent pregnancy, while remaining 3 patients had mucocutaneous and 1 patient had vascular activity. The rate of live birth was 74.1%, abortus was 20.7%, preterm labor was 11.6%, pre-eclampsia was 5.6%, and no congenital fetal abnormality was observed.

Conclusion:

Except for vascular complications, no major organ involvement was described during pregnancy. Higher miscarriage rates were observed compared the healthy pregnancyies. Obstetric complications were not increased and fetal outcomes were not negatively affected by BD. BD is not a contraindication for the onset of pregnancy but control of disease activity before pregnancy, revision of potentially teratogenic agents, and frequent follow-up of patients in view of potential complicaitons are important to minimize risks.

References

1Gul A. Behcet’s disease: an update on the pathogenesis. Clin Exp Rheumatol 2001;19(5 Suppl 24):S6-12.
2Hatemi G, Yazici Y, Yazici H. Behcet’s syndrome. Rheum Dis Clin North Am 2013;39:245-61.
3Martineau M, Haskard DO, Nelson-Piercy C. Behcet’s syndrome in pregnancy. Obstet Med 2010;3:2-7.
4Orgul G, Aktoz F, Beksac MS. Behcet’s disease and pregnancy: what to expect? J Obstet Gynaecol 2018;38:185-8.
5Uzun S, Alpsoy E, Durdu M, Akman A. The clinical course of Behcet’s disease in pregnancy: a retrospective analysis and review of the literature. J Dermatol 2003;30:499-502.
6Merlino L, Del Prete F, Lobozzo B, Priori R, Piccioni MG. Behcet’s disease and pregnancy: a systematic review. Minerva Ginecol 2020;72:332-8.
7Ben-Chetrit E. Behcet’s syndrome and pregnancy: course of the disease and pregnancy outcome. Clin Exp Rheumatol 2014;32(4 Suppl 84):S93-8.
8Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 1990;335:1078-80.
9Djokanovic N, Klieger-Grossmann C, Pupco A, Koren G. Safety of infliximab use during pregnancy. Reprod Toxicol 2011;32:93-7.
10Iskender C, Yasar O, Kaymak O, Yaman ST, Uygur D, Danisman N. Behcet’s disease and pregnancy: a retrospective analysis of course of disease and pregnancy outcome. J Obstet Gynaecol Res 2014;40:1598-602.
11Barros T, Braga A, Marinho A, Braga J. Behcet’s Disease and Pregnancy: A Retrospective Case-control Study. Yale J Biol Med 2021;94:585-92.
12Bang D, Chun YS, Haam IB, Lee ES, Lee S. The influence of pregnancy on Behcet’s disease. Yonsei Med J 1997;38:437-43.
13Jadaon J, Shushan A, Ezra Y, Sela HY, Ozcan C, Rojansky N. Behcet’s disease and pregnancy. Acta Obstet Gynecol Scand 2005;84:939-44.
14Marsal S, Falga C, Simeon CP, Vilardell M, Bosch JA. Behcet’s disease and pregnancy relationship study. Br J Rheumatol 1997;36:234-8.
15Noel N, Wechsler B, Nizard J, et al. Behcet’s disease and pregnancy. Arthritis Rheum 2013;65:2450-6.
16Lee S, Czuzoj-Shulman N, Abenhaim HA. Behcet’s disease and pregnancy: obstetrical and neonatal outcomes in a population-based cohort of 12 million births. J Perinat Med 2019;47:381-7.
17Komaba H, Takeda Y, Fukagawa M. Extensive deep vein thrombosis in a postpartum woman with Behcet’s disease associated with nephrotic syndrome. Kidney Int 2007;71:6.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House